BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Sanomedics International Holdings Inc. Signs Letter of Intent to Acquire Large Sleep Disorder Service Based Operation


12/12/2011 10:50:15 AM

MIAMI, Dec. 12, 2011 /PRNewswire/ -- (Pink Sheets: SIMH) In a shrewd execution of its business plan and growth strategy, Craig Sizer, Co-founder and Chairman, with Keith Houlihan, Co-founder and President of Sanomedics International Holdings Inc. www.sanomedics.com, announced the signing of a letter of intent to acquire a strategically targeted durable medical equipment (DME) provider with a platform in sleep apnea treatment services. The targeted acquisition is accredited by the "Healthcare Quality Association." The operation with approximately $6 million in revenues and over $1 million in (EBITDA) earnings before interest, taxes, depreciation and amortization is expected to close in early 2012 upon the completion of due diligence and Sanomedics board approval.

"The acquisition of a sleep treatment service based operations is an important step in the growth of Sanomedics, as well as for the distribution and sales expansion of our ThermoMedics line of non-contact clinical thermometers," said Craig Sizer Chairman and Co-founder.

The targeted acquisition has a strong patient base and consistent growth over the last five years within the sleep disorder treatment market. It also offers a wide array of durable medical equipment and supplies and over 30 contracts with skilled nursing facilities which manages healthcare for a rapidly aging population.

"This acquisition is the first step in our strategy as a sleep medicine based business, it is a first class operation, with values that fit well with our business growth objectives," said Keith Houlihan, Co-founder and President. "As a pioneer in developing innovative health solutions, this acquisition is a bridge between the high-technology medical world and the growing home healthcare environment."

About Sanomedics
Sanomedics International Holdings, Inc. (SIMH) manufactures and distributes innovative professional medical, as well as, home health diagnostic devices and products. As a pioneer in the trend toward preventive medicine, Sanomedics' goal is to act as a bridge between the high-technology medical world and the home healthcare environment. All Sanomedics professional and home healthcare diagnostic products are extremely easy to use, while providing accurate results in less than one second.

Forward Looking Statements
This press release may contain statements which constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the intent belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. The Company's periodic filings with the Securities and Exchange Commission should be viewed for a complete understanding of risk and uncertainty.

©2011 Sanomedics International Holdings Inc. All rights reserved. www.sanomedics.com

Contact:

Keith Houlihan

Co-Founder and President

305-433-7814

SOURCE Sanomedics International Holdings, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES